Skip to main content

 Scientific publications

Tumor Banks: A Quality Control Scheme Proposal.

Authors : Craciun L, Spinette SA, Rassy M, Salgado R, de Wind A, Demetter P, Verset L, Gomez Galdon M, Chintinne M, Sirtaine N, de St Aubain N, Laios I, Roy F, Larsimont D
Year : 2019
Journal : Front Med (Lausanne)
Volume : 6
Pages : 225

SET<sub>ER/PR</sub>: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer.

Authors : Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R, Tam A, Andreopoulou E, Gong Y, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W
Year : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pages : 16

Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers.

Authors : Tarabichi M, Antoniou A, Le Pennec S, Gacquer D, de Saint-Aubain de Somerhausen N, Craciun L, Cielen T, Laios I, Larsimont D, Andry G, Dumont JE, Maenhaut C, Detours V
Year : 2018
Journal : J Clin Endocrinol Metab
Volume : 103(3)
Pages : 1102-1111

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Authors : Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, OBrien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart M, Michiels S, Lackner MR, Sotiriou C, Loi S
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 1860-6

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Authors : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pages : 217-24

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.

Authors : El Hajj P, Journe F, Wiedig M, Laios I, Sales F, Galibert MD, Van Kempen LC, Spatz A, Badran B, Larsimont D, Awada A, Ghanem G
Year : 2013
Journal : Br J Cancer
Volume : 108(8)
Pages : 1641-7

Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment.

Authors : Leclercq G, Gallo D, Cossy J, Laïos I, Larsimont D, Laurent G, Jacquot Y
Year : 2011
Journal : Curr. Pharm. Des.
Volume : 17(25)
Pages : 2632-53